Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Guru P. Sonpavde

Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma

Journal of Urology

Urology

2018

English

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association With Clinical Outcomes: A Pilot Study

European urology oncology

English

Related publications

Mp71-12 Clinical Benefit of Platinum-Based Neoadjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Carcinoma

Journal of Urology

Urology

2017

English

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Clinical Genitourinary Cancer

Oncology

Urology

2015

English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

English

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy

2013

English

Impact of the Individualization of the First‑line Chemotherapy for Advanced Colorectal Cancer Based on Collagen Gel Droplet‑embedded Drug Sensitivity Test

English

Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma

English

Markov-Modeling for the Administration of Platinum Analogues and Paclitaxel as First-Line Chemotherapy as Well as Topotecan and Liposomal Doxorubicin as Second-Line Chemotherapy With Epithelial Ovarian Carcinoma

Journal of Cancer Research and Clinical Oncology

English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer

Cancer Research

Oncology

2018

English

Optimal First‐line Treatment for Advanced Thymic Carcinoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Guru P. Sonpavde

Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association With Clinical Outcomes: A Pilot Study

Related publications

Mp71-12 Clinical Benefit of Platinum-Based Neoadjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Carcinoma

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Impact of the Individualization of the First‑line Chemotherapy for Advanced Colorectal Cancer Based on Collagen Gel Droplet‑embedded Drug Sensitivity Test

Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Markov-Modeling for the Administration of Platinum Analogues and Paclitaxel as First-Line Chemotherapy as Well as Topotecan and Liposomal Doxorubicin as Second-Line Chemotherapy With Epithelial Ovarian Carcinoma

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Optimal First‐line Treatment for Advanced Thymic Carcinoma